Consun Pharmaceutical Group Limited (FRA:C1P)
Germany
· Delayed Price · Currency is EUR 1.190
+0.260 (27.96%)
Last updated: May 13, 2025
FRA:C1P Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 910.46 | 784.53 | 682.91 | 590.17 | 498.79 | Upgrade
|
| Depreciation & Amortization | 63.99 | 78.09 | 76.36 | 72.99 | 71.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.35 | 0.85 | 4.12 | 1.99 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.09 | -0.23 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.07 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | -1.78 | 23.41 | 12.17 | Upgrade
|
| Provision & Write-off of Bad Debts | -8.78 | -12.6 | -32.49 | -18.04 | 29.36 | Upgrade
|
| Other Operating Activities | -33.07 | -14.33 | 39.93 | -90.34 | -52.41 | Upgrade
|
| Change in Accounts Receivable | -27.9 | -1.71 | 113.87 | 114.21 | 304.46 | Upgrade
|
| Change in Inventory | 77.41 | -89.69 | -54.9 | -39.56 | -28.5 | Upgrade
|
| Change in Accounts Payable | 116.92 | 80.76 | 114.41 | 50.99 | 41.43 | Upgrade
|
| Change in Unearned Revenue | -4.55 | -0.46 | 2.26 | 1.67 | -1.14 | Upgrade
|
| Change in Other Net Operating Assets | -8.01 | -6.24 | 3 | 18.04 | -9.14 | Upgrade
|
| Operating Cash Flow | 1,087 | 818.97 | 947.68 | 725.54 | 867.06 | Upgrade
|
| Operating Cash Flow Growth | 32.73% | -13.58% | 30.62% | -16.32% | 126.20% | Upgrade
|
| Capital Expenditures | -109 | -52.56 | -51.59 | -98.25 | -48.7 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.33 | 0.15 | 1.2 | 0.32 | 0.11 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -5 | Upgrade
|
| Investment in Securities | -143.06 | -248.27 | -365.67 | -230 | - | Upgrade
|
| Other Investing Activities | 64.82 | 68.92 | 47.26 | 29.62 | 27.89 | Upgrade
|
| Investing Cash Flow | -186.91 | -231.77 | -368.8 | -298.31 | -25.7 | Upgrade
|
| Long-Term Debt Issued | 497.55 | 442.39 | 259.32 | 295.72 | 263.76 | Upgrade
|
| Total Debt Issued | 497.55 | 442.39 | 259.32 | 295.72 | 263.76 | Upgrade
|
| Long-Term Debt Repaid | -758.2 | -382.93 | -436.67 | -235.81 | -237.92 | Upgrade
|
| Total Debt Repaid | -758.2 | -382.93 | -436.67 | -235.81 | -237.92 | Upgrade
|
| Net Debt Issued (Repaid) | -260.65 | 59.46 | -177.35 | 59.91 | 25.83 | Upgrade
|
| Issuance of Common Stock | 142.99 | 14.2 | 2.64 | 14.57 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -29.07 | -30.15 | -152.75 | Upgrade
|
| Common Dividends Paid | -680.54 | -326.25 | -127.49 | -198.08 | -131.49 | Upgrade
|
| Other Financing Activities | 68.94 | -27.51 | -10.93 | -12.91 | -21.4 | Upgrade
|
| Financing Cash Flow | -729.26 | -280.1 | -342.21 | -166.66 | -279.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | -11.4 | -9.01 | 17.18 | -4.52 | -4.51 | Upgrade
|
| Net Cash Flow | 159.42 | 298.09 | 253.85 | 256.05 | 557.04 | Upgrade
|
| Free Cash Flow | 977.99 | 766.41 | 896.09 | 627.29 | 818.36 | Upgrade
|
| Free Cash Flow Growth | 27.61% | -14.47% | 42.85% | -23.35% | 302.00% | Upgrade
|
| Free Cash Flow Margin | 32.96% | 29.59% | 38.30% | 30.68% | 46.69% | Upgrade
|
| Free Cash Flow Per Share | 1.18 | 0.96 | 1.13 | 0.78 | 1.00 | Upgrade
|
| Cash Interest Paid | 0.41 | 1.09 | 0.56 | 12.91 | 21.4 | Upgrade
|
| Cash Income Tax Paid | 37.18 | 20.03 | 13.21 | 134.68 | 115.32 | Upgrade
|
| Levered Free Cash Flow | 681.72 | 507.99 | 650.74 | 464.15 | 708.42 | Upgrade
|
| Unlevered Free Cash Flow | 697.28 | 521.28 | 657.57 | 472.21 | 721.8 | Upgrade
|
| Change in Net Working Capital | -132.92 | 20.45 | -187.46 | -61.45 | -347.71 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.